These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6651279)

  • 1. Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function.
    Lau A; Lee M; Flascha S; Prasad R; Sharifi R
    Antimicrob Agents Chemother; 1983 Oct; 24(4):533-7. PubMed ID: 6651279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.
    Halstenson CE; Hirata CA; Heim-Duthoy KL; Abraham PA; Matzke GR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):128-33. PubMed ID: 2327747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tobramycin inactivation by carbenicillin, ticarcillin, and piperacillin.
    Konishi H; Goto M; Nakamoto Y; Yamamoto I; Yamashina H
    Antimicrob Agents Chemother; 1983 May; 23(5):653-7. PubMed ID: 6223576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating possible pharmacokinetic interactions between tobramycin, piperacillin, and a combination of piperacillin and tazobactam in patients with various degrees of renal impairment.
    Dowell JA; Korth-Bradley J; Milisci M; Tantillo K; Amorusi P; Tse S
    J Clin Pharmacol; 2001 Sep; 41(9):979-86. PubMed ID: 11549103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.
    King CH; Creger RJ; Ellner JJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):285-90. PubMed ID: 3994344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.
    Péchère JC; Dugal R
    J Infect Dis; 1976 Aug; 134 Suppl():S118-24. PubMed ID: 972269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin.
    Hale DC; Jenkins R; Matsen JM
    Am J Clin Pathol; 1980 Sep; 74(3):316-9. PubMed ID: 6447998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the antibiotics piperacillin, doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits.
    Iven H; Brasch H
    Cancer Chemother Pharmacol; 1986; 17(3):218-22. PubMed ID: 3742705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin sulfate elimination in premature infants.
    Arbeter AM; Saccar CL; Eisner S; Sarni E; Yaffe SJ
    J Pediatr; 1983 Jul; 103(1):131-5. PubMed ID: 6864378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization and Evaluation of Piperacillin-Tobramycin Combination Dosage Regimens against Pseudomonas aeruginosa for Patients with Altered Pharmacokinetics via the Hollow-Fiber Infection Model and Mechanism-Based Modeling.
    Yadav R; Rogers KE; Bergen PJ; Bulitta JB; Kirkpatrick CMJ; Wallis SC; Paterson DL; Nation RL; Lipman J; Roberts JA; Landersdorfer CB
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ticarcillin on gentamicin and tobramycin pharmacokinetics in a patient with end-stage renal disease.
    Matzke GR; Luckham DR; Collins AJ; Halstenson CE
    Pharmacotherapy; 1984; 4(3):158-60. PubMed ID: 6739313
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of piperacillin in subjects with various degrees of renal function.
    Welling PG; Craig WA; Bundtzen RW; Kwok FW; Gerber AU; Madsen PO
    Antimicrob Agents Chemother; 1983 Jun; 23(6):881-7. PubMed ID: 6225390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo inactivation of tobramycin by piperacillin.
    Uber WE; Brundage RC; White RL; Brundage DM; Bromley HR
    DICP; 1991 Apr; 25(4):357-9. PubMed ID: 1926903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic interactions of biofilms of mucoid Pseudomonas aeruginosa with tobramycin and piperacillin.
    Anwar H; Strap JL; Chen K; Costerton JW
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1208-14. PubMed ID: 1416820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration.
    Tjandramaga TB; Mullie A; Verbesselt R; De Schepper PJ; Verbist L
    Antimicrob Agents Chemother; 1978 Dec; 14(6):829-37. PubMed ID: 742871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of piperacillin on pharmacokinetics of etimicin in healthy volunteers.
    Wang HX; Zhang LR; Ma XC; Ma TX
    Acta Pharmacol Sin; 2002 Apr; 23(4):376-80. PubMed ID: 11931698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help?
    Crass RL; Pai MP; Lodise TP
    J Antimicrob Chemother; 2019 Jan; 74(1):126-129. PubMed ID: 30252050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.
    Bauer LA; Blouin RA
    Eur J Clin Pharmacol; 1983; 24(5):639-42. PubMed ID: 6873143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose dependence of piperacillin pharmacokinetics.
    Bergan T; Williams JD
    Chemotherapy; 1982; 28(3):153-9. PubMed ID: 6212203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age on tobramycin pharmacokinetics in patients with normal renal function.
    Bauer LA; Blouin RA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):587-9. PubMed ID: 7325627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.